Volume 9A of the Rules Governing Medicinal Products in the European Union: What Does It All Mean? Part 2

May 04, 2007

Drug Information Association, Online May 31 2007 This Webinar will concentrate on the qualitative aspects of the pharmacovigilance system such as compliance, post-authorization safety studies signal detection, and risk management and communication.

Organized by:			Drug Information Association
Invited Speakers:			1)MARIETTE BOERSTOEL-STREEFLAND, MD, MSC (EPI) Executive Director, Pharmacovigilance/Risk Management Forest Research Institute, Forest Laboratories Inc. 2)STEPHEN A. GOLDMAN, MD, FAPA, DFAPM Managing Member Stephen A. Goldman Consulting Services, LLC Adjunct Assistant Professor of Psychiatry, Uniformed Services University of the Health Sciences.

Deadline for Abstracts:			-

Registration:			http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?productID=14227&eventType=Webinar
E-mail:			dia@diahome.org

events